Marex Directors & Officers Buy Company Shares
Ticker: MRX · Form: 6-K · Filed: Oct 15, 2025 · CIK: 1997464
| Field | Detail |
|---|---|
| Company | Marex Group PLC (MRX) |
| Form Type | 6-K |
| Filed Date | Oct 15, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-buy, management
TL;DR
Marex execs buying stock - insider confidence boost?
AI Summary
On October 15, 2025, Marex Group plc announced that its Directors and Officers purchased ordinary shares. The press release detailing these transactions is furnished as Exhibit 99.1.
Why It Matters
Insider share purchases can signal confidence from company leadership in the company's future prospects.
Risk Assessment
Risk Level: low — This filing is an informational update regarding insider share purchases and does not present new financial risks.
Key Players & Entities
- Marex Group plc (company) — The company making the announcement.
- October 15, 2025 (date) — Date of the announcement and share purchases.
FAQ
What type of shares were purchased by Directors and Officers?
The filing states that Directors and Officers purchased ordinary shares.
What is the title of the press release mentioned in the filing?
The press release is titled 'Marex announces share purchases by Directors and Officers'.
Which exhibit contains the press release?
The press release is furnished as Exhibit 99.1.
What is the filing date for this report?
The filing date is October 15, 2025.
What is the principal executive office address of Marex Group plc?
The principal executive offices are located at 155 Bishopsgate, London EC2M 3TQ, United Kingdom.
Filing Stats: 225 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-10-15 09:38:46
Filing Documents
- d920594d6k.htm (6-K) — 10KB
- d920594dex991.htm (EX-99.1) — 11KB
- 0001193125-25-239659.txt ( ) — 22KB
From the Filing
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025 Commission File Number: 001-42020 MAREX GROUP PLC (Translation of registrant's name into English) 155 Bishopsgate London EC2M 3TQ United Kingdom +44 20 7655 6000 140 East 45th Street, 10th Floor New York, New York 10017 (212) 618-2800 (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-FForm 40-F EXPLANATORY NOTE Purchase of Ordinary Shares by Directors and Officers On October 15, 2025, Marex Group plc (the "Company") issued a press release titled "Marex announces share purchases by Directors and Officers". A copy of the press release is furnished as Exhibit 99.1 herewith. EXHIBIT INDEX The following exhibit is furnished as part of this Form 6-K: Exhibit No. Description 99.1 Press release dated October 15, 2025 titled "Marex announces share purchases by Directors and Officers" SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Marex Group plc Date: October 15, 2025 By: /s/ Robert Irvin Robert Irvin Chief Financial Officer